Multiple Myeloma

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
06971
A Phase III Study of PSC-833 in Combination with Vincristine, Doxorubicin and Dexamethasone (PSC-833/VAD) versus VAD Alone in Patients with Relapsing and Refractory Multiple Myeloma
06923
Randomized phase III study testing the effect of bone marrow transplantation or conventional chemotherapy with or without alpha Interferon for aggressive myeloma
06914
Phase II-III study of VAD (Vincristine, Doxorubicin, Dexamethasone) versus VAD plus Cyclosporin in patients with progressive multiple myeloma
06913
Pilot Study of VAD (vincristine, doxorubicin, dexamethasone) combined with cyclosporin in patients with progressive multiple myeloma.

Back to Site-list